Polymorphisms in beta-adrenergic receptor genes in the acquired long QT syndrome

Journal of Cardiovascular Electrophysiology

Volumn 13, Issue 3, 2002, Pages 252-256

  Kanki, Hideaki ^a   Yang, Ping ^a   Xie, Hong Guang ^a   Kim, Richard B ^a   George Jr , Alfred L ^a   Roden, Dan M ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Adrenergic receptors; Arrhythmia; Long QT interval

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HUMAN; LONG QT SYNDROME; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; SYMPATHETIC TONE; TORSADE DES POINTES;

EID: 0036194009     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2002.00252.x     Document Type: Article

References (45)

1. Quinidine syncope, paroxysmal ventricular fibrillations occurring during treatment of chronic atrial arrhythmias
2. Inherited long QT syndromes: A paradigm for understanding arrhythmogenesis
3. Thioridazine-induced torsades de pointes: Successful therapy with isoproterenol
4. Cisapride and fatal arrhythmia
5. Mechanism of the cardiotoxic actions of terfenadine
6. Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences
7. Torsades de pointes induced by erythromycin
8. Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: A review of the literature and possible mechanisms
9. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure
10. Increased sensitivity to QT prolonging drug therapy immediately after cardioversion to sinus rhythm
11. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias
12. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome
13. A common polymorphism associated with antibiotic-induced cardiac arrhythmia
14. Ks potassium channels
15. Frequency of ion channel mutations and polymorphisms in a large population of patients with drug-associated long QT syndrome
16. Do mutations in cardiac ion channel genes predispose to drug-induced (acquired) long QT syndrome?
17. Cellular basis for the ECG features of the LQTt1 form of the long-QT syndrome: Effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes
18. Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias
19. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome
20. Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: Quantitative analysis of Holter recordings
21. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness
22. Common polymorphisms of beta1-adrenoceptor: Identification and rapid screening assay
23. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor
24. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects
25. A DNA polymorphism discovery resource for research on human genetic variation
26. Frequency of functionally important beta2-adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals
27. Beta1-adrenoceptor gene variations: A role in idiopathic dilated cardiomyopathy?
28. Population frequency, mutation linkage and analytical methodology for the Arg16Gly, Gln27Glu and Thr164Ile polymorphisms in the beta2-adrenergic receptor among Turks
29. Human beta2-adrenergic receptor polymorphisms: No association with essential hypertension in black or white Americans
30. Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure
31. Association of beta(2)-adrenoreceptor variants with bronchial hyperresponsiveness
32. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs
33. Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy
34. A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure
35. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties
36. Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells
37. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma
38. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing
39. Norepinephrine release in the human forearm: Effects of epinephrine
40. Beta-adrenergic receptor alterations in hypertension: Physiological and molecular correlates
41. Low sodium corrects an abnormality in beta-receptor-mediated arterial vasodilation in hypertensives: Correlation with beta-receptor function in vivo
42. Dietary sodium intake modulates systemic but not forearm norepinephrine release
43. The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure
44. A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor
45. Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice